Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular

María Cristina Saccheri1, Tomás Francisco Cianciulli1,2, Wilde Challapa Licidio1

  • 1Echocardiography Laboratory, Division of Cardiology, Hospital General de Agudos del Gobierno de la Ciudad de Buenos Aires "Dr. Cosme Argerich, Buenos Aires, Argentina.

Insights

Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) both cause left ventricular hypertrophy, but FD is associated with a smaller left atrial volume. Both conditions severely impair left atrial function, indicating atrial cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) are distinct conditions causing left ventricular hypertrophy and fibrosis.
  • While left atrial (LA) remodeling in HCM is linked to atrial fibrillation, LA changes in FD remain understudied.

Purpose of the Study:

  • To compare left atrial size and mechanical function in patients with non-obstructive HCM and Fabry cardiomyopathy.
  • To investigate the presence of atrial cardiomyopathy in FD using speckle tracking echocardiography.

Main Methods:

  • Prospective study comparing 19 HCM patients, 20 FD patients, and 20 controls.
  • Echocardiography used to measure left ventricular mass, LA volume, and LA mechanical function (strain and strain rate).
  • Speckle tracking assessed reservoir, conduit, and contraction phases of LA function.

Main Results:

  • Patients with HCM had significantly larger LA volumes than those with FD (48.16 vs. 38.9 mL/m²).
  • Both HCM and FD groups exhibited severe reductions in LA reservoir strain and strain rate during all three functional phases.
  • No significant differences in LA function parameters were observed between the HCM and FD groups.

Conclusions:

  • Fabry disease is associated with atrial cardiomyopathy, impacting all three phases of LA mechanical function.
  • Despite larger LA volumes in HCM, both conditions demonstrate similarly impaired LA function.
  • These findings highlight the significant atrial involvement in FD and HCM, with potential clinical implications.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
611
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
767
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
593
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470